All In MedTech

FDA Clearance Tracker · P870077

CARPENTIER-EDWARDS DURAFLEX LOW PRESSURE MITRAL BIOPROSTHESIS

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Sep 25, 1991 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Sep 25, 1991

Approval withdrawn

Time to decision

1,388 days

Received Dec 7, 1987. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P870077
Device name
CARPENTIER-EDWARDS DURAFLEX LOW PRESSURE MITRAL BIOPROSTHESIS
Applicant location
Irvine, CA
Received
Dec 7, 1987
Decided
Sep 25, 1991
Decision
Approval withdrawn
Supplements
56 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 870.3925

Every decision under product code DYE

FDA's approval statement

As written in FDA's record.

Approval for the Carpentier-Edwards® Duraflex™ Bioprosthesis, Models 6625 LP and 6625-ESR-LP. These devices are intended for use in patients whose mitral valvular disease is sufficiently advanced to warrant replacement of their natural valve with a prosthetic one. It is also intended for use in patients with a previously implanted mitral valve prosthesis which is no longer functioning adequately and requires replacement.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code DYE. The earliest in FDA's data is P870078, decided Sep 28, 1989.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.